Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Barst

Chest

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Chest|January 13, 2000
Experience and reasonR J Barst
Chest|April 1, 1986
Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertensionR J Barst
Chest|November 13, 1999
Do no harmR J Barst
Chest|July 23, 1998
Pulmonary vascular disease: our need to understandR J Barst
Chest|September 19, 1998
Genetics and immunogenetic aspects of primary pulmonary hypertensionR J Barst, J E Loyd
Chest|October 1, 1985
Endothelial function in clinical pulmonary hypertensionR J Barst, S A Stalcup
Chest|October 26, 1999
Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertensionD Wax, R Garofano, R J Barst
Chest|October 18, 2000
Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosusE M Horn, R J Barst, M Poon
Chest|September 24, 1999
Hormone replacement therapy: a possible risk factor in carriers of familial primary pulmonary hypertensionJ H Morse, E M Horn, R J Barst
Chest|June 16, 2001
Pulmonary arterial hypertension and thyroid diseaseA Ferris, T Jacobs, A Widlitz, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Chest|January 13, 2000
Experience and reasonR J Barst
Chest|April 1, 1986
Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertensionR J Barst
Chest|November 13, 1999
Do no harmR J Barst
Chest|July 23, 1998
Pulmonary vascular disease: our need to understandR J Barst
Chest|September 19, 1998
Genetics and immunogenetic aspects of primary pulmonary hypertensionR J Barst, J E Loyd
Chest|October 1, 1985
Endothelial function in clinical pulmonary hypertensionR J Barst, S A Stalcup
Chest|October 26, 1999
Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertensionD Wax, R Garofano, R J Barst
Chest|October 18, 2000
Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosusE M Horn, R J Barst, M Poon
Chest|September 24, 1999
Hormone replacement therapy: a possible risk factor in carriers of familial primary pulmonary hypertensionJ H Morse, E M Horn, R J Barst
Chest|June 16, 2001
Pulmonary arterial hypertension and thyroid diseaseA Ferris, T Jacobs, A Widlitz, et al.
Pageof 2